Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease.

Details

Ressource 1Download: 32513242_BIB_7D6E611F997B.pdf (851.95 [Ko])
State: Public
Version: Final published version
License: CC BY 4.0
Serval ID
serval:BIB_7D6E611F997B
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
UNIL/CHUV
Title
Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease.
Journal
Critical care
Author(s)
Liaudet L., Szabo C.
ISSN
1466-609X (Electronic)
ISSN-L
1364-8535
Publication state
Published
Issued date
08/06/2020
Peer-reviewed
Oui
Volume
24
Number
1
Pages
318
Language
english
Notes
Publication types: Journal Article
Publication Status: epublish
Keywords
COVID-19, Coronavirus Infections/drug therapy, Humans, Mineralocorticoid Receptor Antagonists/therapeutic use, Pandemics, Pneumonia, Viral/drug therapy, Severity of Illness Index, Spironolactone/therapeutic use
URN
urn:nbn:ch:serval-BIB_7D6E611F997B0
OAI-PMH
oai:serval.unil.ch:BIB_7D6E611F997B
DOI
10.1186/s13054-020-03055-6
Pubmed
32513242
Web of science
000541099600013
Open Access
Yes
Create date
10/06/2020 15:02
Last modification date
08/08/2024 6:36
Usage data